Cancer supportive care products can be defined as products or drugs that are mainly used for treatment of adverse effects associated with cancer therapy
Cancer Supportive Care Products can be defined as products or drugs which are mainly useful for treatment of undesireable effects connected with cancer therapy in addition to for treatment of symptoms and signs of cancer such nausea, vomiting, hair thinning, low blood counts, and others. The Cancer Supportive Care Products could be classified on the inspiration of drug class that will be further categorised into monoclonal antibodies, opioid analgesics, nonsteroidal erythropoietin stimulating agents, anti-infective drugs, granulocyte colony stimulating factor, anti-emetics drugs, bisphosphonates, and anti-inflammatory drugs. Moreover, entry of biosimilars can be expected to limit growth of the global cancer supportive care products market. Patents for many major drugs used in cancer supportive care products have expired or are expected to expire in the near future. This really is projected to open the gateway for biosimilars for anti-cancer therapy, which wo...